Orthofix Medical Inc. (OFIX) Guidance & Earnings Results
On 2026-08-05 Orthofix Medical Inc. raised guidance: "Net sales +$7M at both ends; adj EBITDA +$5M at both…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OFIXOrthofix Medical Inc.Follow OFIX — free
—
Price chart with a free account
- Market cap
- 399.6M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Raised | Net sales +$7M at both ends; adj EBITDA +$5M at both ends · full year |
| 9 Apr 26 | Reaffirmed | Net sales $850-860M; adj. EBITDA $95-98M; positive FCF · full year |
| 24 Feb 26 | Raised | 2026 financial guidance provided; three-year targets updated · full year |
| 4 Nov 25 | Raised | Net sales guidance narrowed to $810-814M (midpoint maintained); low-end of adjusted EBITDA raised · full year |
| 5 Aug 25 | Reaffirmed | FY2025 pro forma net sales $808-816M; FY2025 pro forma non-GAAP adjusted EBITDA $82-86M; FY2025 free cash flow positive · full year |
Orthofix Medical Inc. — questions
- What guidance did Orthofix Medical Inc. give?
- On 2026-08-05: "Net sales +$7M at both ends; adj EBITDA +$5M at both ends"
- When does Orthofix Medical Inc. report earnings?
- Orthofix Medical Inc.'s next earnings report is expected on 2026-11-11.
Every figure on this page comes from Orthofix Medical Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.